» Articles » PMID: 16299227

Clear Cell Sarcoma of the Kidney: Up-regulation of Neural Markers with Activation of the Sonic Hedgehog and Akt Pathways

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2005 Nov 22
PMID 16299227
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose And Experimental Design: Clear cell sarcoma of the kidney (CCSK), the second most common renal tumor in children, poses significant diagnostic challenges. No positive diagnostic markers are available, and the pathogenesis of CCSK remains an enigma. To address these challenges, the gene expression patterns of 14 CCSKs were compared with 15 Wilms tumors and 3 fetal kidney samples using oligonucleotide arrays.

Results: Using unsupervised methods, the gene expression profile of CCSK was distinctive: differentially expressed genes could largely be grouped into four categories: (a) a wide variety of neural markers, (b) members of the Sonic hedgehog pathway, (c) members of the phosphoinositide-3-kinase/Akt cell proliferation pathway, and (d) known therapeutic targets. Corresponding changes in critical proteins using Western blot and/or immunohistochemistry confirmed the up-regulation of these pathways and proteins. In particular, CD117 and epidermal growth factor receptor are up-regulated at the protein level in many CCSKs, providing potential therapeutic targets. One of the neural markers, nerve growth factor receptor, represents a promising diagnostic tool for CCSK.

Conclusions: This study suggests that CCSKs arise within a renal mesenchymal cell that shows a wide variety of neural markers. As such, it seems to be susceptible to genetic changes also seen in a variety of other neuroectodermal and neuronal tumors, including activation of Sonic hedgehog and phosphoinositide-3-kinase/Akt pathways. Involvement of these pathways in CCSKs implicates their widening role in tumorigenesis.

Citing Articles

Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.

Perotti D, OSullivan M, Walz A, Davick J, Al-Saadi R, Benedetti D Nat Rev Urol. 2025; .

PMID: 39881003 DOI: 10.1038/s41585-024-00993-6.


Paediatric renal tumours: an update on challenges and recent developments.

Somers G, LHermine-Coulomb A, Matoso A, OSullivan M Virchows Arch. 2025; 486(1):49-64.

PMID: 39786574 DOI: 10.1007/s00428-024-04017-x.


An integrated bioinformatic investigation of kallikrein gene family members in kidney renel cell carcinoma.

Wang B, Yang L, Qin H, Li F, Zhang P PLoS One. 2024; 19(8):e0305070.

PMID: 39116105 PMC: 11309392. DOI: 10.1371/journal.pone.0305070.


Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.

Zheng J, Liu F, Tuo J, Chen S, Su J, Ou X Mol Biotechnol. 2024; 66(5):1132-1143.

PMID: 38195816 DOI: 10.1007/s12033-023-01008-2.


Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).

Fiore M, Taddia A, Indio V, Bertuccio S, Messelodi D, Serravalle S Int J Mol Sci. 2023; 24(4).

PMID: 36835166 PMC: 9964999. DOI: 10.3390/ijms24043743.